Hepatic encephalopathy: Ever closer to its big bang

Pablo A Souto1, Ariel R Marcotegui1, Lisandro Orbea1

  • 1Pablo A Souto, Ariel R Marcotegui, Lisandro Orbea, Juan Skerl, Juan Carlos Perazzo, Department of Pathology, Laboratory of Hyperammonemia and Hepatic Encephalopathy, Center of Applied and Experimental Pathology, Faculty of Medicine, University of Buenos Aires, Buenos Aires 1053, Argentina.

Insights

Minimal hepatic encephalopathy (MHE) is an early sign of liver disease, impacting cognition and survival. Research highlights skeletal muscle and the gut as key players in ammonia detoxification, offering new avenues for understanding MHE.

Area of Science:

  • Neuroscience
  • Gastroenterology
  • Metabolic Disorders

Background:

  • Hepatic encephalopathy (HE) is a neuropsychiatric complication of liver disease with unclear pathogenesis.
  • Minimal hepatic encephalopathy (MHE) affects over 75% of liver cirrhosis patients, causing subtle cognitive impairment.
  • MHE is linked to impaired driving, daily activities, and increased mortality.

Discussion:

  • Skeletal muscle can shift to detoxify ammonia, becoming crucial in chronic liver failure.
  • Muscular glutamine-synthetase activity is vital due to impaired liver and brain metabolism.
  • The gut is a primary site for glutamine consumption and ammonia production.
  • Hepatocellular dysfunction impairs ammonium clearance and inter-organ trafficking.
  • Intestinal bacteria contribute to ammonia production; bacterial overgrowth is common in cirrhosis.

Key Insights:

  • Focusing on MHE offers insights into the 'big bang' of hepatic encephalopathy.
  • Skeletal muscle and the gut represent under-explored pathways in HE pathogenesis.
  • Understanding ammonia's inter-organ trafficking is key to managing MHE.

Outlook:

  • Further research into skeletal muscle and gut roles in ammonia metabolism is warranted.
  • Exploring novel therapeutic targets within these organs could improve MHE management.
  • Investigating the gut-liver-muscle axis may elucidate HE's complex pathophysiology.

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
247
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
307
Disorders of the Nervous Tissue01:28

Disorders of the Nervous Tissue

Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
3.0K
Hepatic Drug Excretion: Enterohepatic Cycling01:17

Hepatic Drug Excretion: Enterohepatic Cycling

Enterohepatic cycling involves the active secretion of drugs and their metabolites into the bile via transporters in the canalicular membrane of hepatocytes. This secretion is an integral part of the digestive process, releasing these substances into the gastrointestinal (GI) tract.
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
3.2K
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.6K
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders01:27

Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders

Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
2.3K